Project description
New approach protects neonatal intensive care units from resistant bacteria
Critically ill babies are highly vulnerable to drug-resistant bacteria. The EU-funded NeoIPC project therefore focuses on the prevention and management of resistant bacterial colonisation and infection in neonatal intensive care units. Researchers will develop and implement an innovative approach for evaluating infection prevention and control (IPC) interventions, combining a randomised trial with the assessment of a suitable implementation science strategy and novel targeted clinical and genotypic surveillance. NeoIPC will also devise Europe-wide network strategies for improving IPC in routine neonatal care. The project will thus provide globally transferable methods for reducing hospital transmission of resistant pathogens, promoting collaborative research and IPC implementation efforts with a broad and long-lasting impact for critically ill newborns and infants.
Fields of science
Programme(s)
Funding Scheme
RIA - Research and Innovation actionCoordinator
35122 Padova
Italy
See on map
Participants (12)
SW17 0RE London
See on map
3584 CX Utrecht
See on map
8006 Zurich
See on map
51005 Tartu
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
4123 Allschwil
See on map
54636 Thessaloniki
See on map
2000 Antwerpen
See on map
10117 Berlin
See on map
01006 Vitoria-gasteiz
See on map
Legal entity other than a subcontractor which is affiliated or legally linked to a participant. The entity carries out work under the conditions laid down in the Grant Agreement, supplies goods or provides services for the action, but did not sign the Grant Agreement. A third party abides by the rules applicable to its related participant under the Grant Agreement with regard to eligibility of costs and control of expenditure.
48903 Barakaldo Bizkaia
See on map
7600 Stellenbosch
See on map
35127 Padova
See on map